Australian Stingless Bees Show Promise in Combating Antibiotic Resistance
Research reveals that honey and propolis from Australia's native stingless bees could be key in fighting drug-resistant infections.
Honey from Tetragonula carbonaria effectively inhibits multiple harmful bacteria and fungi.
Propolis shows selective antifungal properties, potentially protecting beneficial fungi.
Further research is needed to develop medical applications and assess safety.
A recent study highlights the potential of honey and propolis from Australia's native stingless bees in addressing the growing threat of antibiotic resistance. Conducted by researchers and published in PLOS One, the study tested the antimicrobial properties of honey and propolis from the Tetragonula carbonaria species against 16 types of bacteria and fungi known to cause human diseases. The findings reveal that the honey effectively halted the growth of all tested bacteria, while the propolis displayed strong antifungal activity against specific strains.
Australia is home to around 11 species of stingless bees, with Tetragonula carbonaria being prevalent along the eastern coast. Indigenous Australians have long valued the honey, known as sugarbag, for its medicinal properties. Unlike honeybee hives, stingless bees construct their nests using propolis, which contributes to the antimicrobial properties of their honey. This unique composition allows their honey to remain free from harmful microbes, even with a higher water content compared to traditional honey.
The study's results indicate that native bee honey can inhibit pathogens such as golden staph and E. coli, as well as fungi responsible for conditions like ringworm. Unlike honeybee honey, which produces hydrogen peroxide that diminishes quickly, stingless bee honey can maintain its antimicrobial activity for up to a week. Furthermore, it retains its effectiveness even after the peroxide is removed, suggesting the presence of other beneficial compounds.
The implications of these findings extend beyond individual health. As antibiotic-resistant infections rise globally, the potential for using natural products like stingless bee honey in medical applications could provide an alternative to conventional antibiotics. However, challenges remain, including the need for further testing to ensure safety and efficacy in clinical settings, as well as the limited honey production from stingless bee colonies.
Looking ahead, researchers aim to develop suitable formulations for medical use and explore the specific compounds responsible for the antimicrobial effects. With growing interest in sustainable beekeeping, there is potential for increased production of native bee honey, which could play a significant role in future antimicrobial therapies.
